| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10897-016-9934-0 |
| P698 | PubMed publication ID | 26879922 |
| P50 | author | Komal Bajaj | Q57694619 |
| P2093 | author name string | Laura Hercher | |
| Kathleen Erskine Aaron | |||
| Emily Suskin | |||
| P2860 | cites work | Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics | Q61847812 |
| Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population | Q61847837 | ||
| Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype | Q81886736 | ||
| Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting | Q83395075 | ||
| Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q84195901 | ||
| Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy | Q85495453 | ||
| Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening | Q86607373 | ||
| #36: Prenatal aneuploidy screening using cell-free DNA | Q86999138 | ||
| DNA Sequencing versus Standard Prenatal Aneuploidy Screening | Q22250872 | ||
| Non-invasive prenatal testing: a review of international implementation and challenges | Q26999426 | ||
| DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study | Q34029044 | ||
| Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort | Q34088575 | ||
| Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. | Q34340985 | ||
| Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing | Q34433169 | ||
| A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States | Q35680437 | ||
| An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population | Q35686965 | ||
| Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities | Q35856339 | ||
| Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis | Q36647328 | ||
| Role of First-Trimester Sonography in the Diagnosis of Aneuploidy and Structural Fetal Anomalies | Q37793748 | ||
| Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks | Q37826400 | ||
| Turning the pyramid of prenatal care | Q37851291 | ||
| Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma | Q38087410 | ||
| ACMG statement on noninvasive prenatal screening for fetal aneuploidy. | Q38096182 | ||
| Non-invasive prenatal testing for aneuploidy: current status and future prospects | Q38114375 | ||
| Changing to NIPT as a first-tier screening test and future perspectives: opinions of health professionals | Q38959581 | ||
| Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. | Q39024055 | ||
| First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes | Q39880571 | ||
| Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. | Q41235376 | ||
| Prenatal Testing in the Genomic Age: Clinical Outcomes, Quality of Life, and Costs | Q41392199 | ||
| Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. | Q41566460 | ||
| Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. | Q43418239 | ||
| Genetic counselors' experience with cell-free fetal DNA testing as a prenatal screening option for aneuploidy | Q43570601 | ||
| First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing | Q43905798 | ||
| Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? | Q43943228 | ||
| Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors | Q44274066 | ||
| NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy | Q44299715 | ||
| ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan | Q45124575 | ||
| Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors | Q46446186 | ||
| Cell-free DNA analysis for noninvasive examination of trisomy | Q46784231 | ||
| First-trimester or second-trimester screening, or both, for Down's syndrome | Q46799629 | ||
| Chromosome abnormalities detected by current prenatal screening and noninvasive prenatal testing | Q46877513 | ||
| Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
| Noninvasive prenatal testing and fetal sonographic screening: roundtable discussion. | Q52837725 | ||
| Positive predictive value of cell free DNA analysis. | Q53073212 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 1032-1043 | |
| P577 | publication date | 2016-02-15 | |
| P1433 | published in | Journal of Genetic Counseling | Q6295247 |
| P1476 | title | The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice | |
| P478 | volume | 25 |
| Q61448634 | Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences |
| Q89303078 | Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians |
| Q48106979 | Implementing Group Prenatal Counseling for Expanded Noninvasive Screening Options |
| Q64236032 | Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis |
Search more.